Smallpox is an infectious disease caused by variola virus, an orthopoxvirus, and is discussed in the supplied literature as a historical human disease with important relevance to vaccine preparedness [1][2]. The sources characterize it as a poxvirus infection of major concern for public-health planning and as a biological threat because of its potential relevance to biological warfare and bioterrorism [1]. Source-backed detail on its full clinical taxonomy or current endemic status is not yet available in the supplied material [2][1].
Disease Profile
Smallpox
天花
Smallpox is a historical orthopoxvirus disease of major public-health significance, with variola virus highlighted in the literature as the poxvirus most frequently associated with severe pulmonary complications before eradication in 1980 [1]. The provided sources also note ongoing reference to smallpox in vaccine-development and preparedness discussions, including its inclusion among vaccines considered for strategic stockpiling [2]. Source-backed detail on present-day incidence and routine community circulation is not yet available in the supplied material [2][1].
The supplied material indicates that poxvirus infections in humans usually cause skin lesions, and that clinical course may be complicated by viral pneumonia in some cases [1]. For smallpox specifically, the source notes that pneumonia can be severe and may progress to acute respiratory distress syndrome and death [1]. No further source-backed detail on the typical rash evolution, symptom timing, or complication spectrum is available in the provided snippets [1].
Historically, variola virus was associated with many large outbreaks worldwide before eradication in 1980 [1]. The provided sources do not give contemporary burden estimates for smallpox itself, but they do show that smallpox remains present in the literature on pandemic preparedness and vaccine stockpiling [2][1]. The available material also distinguishes historical smallpox from monkeypox/orthopoxvirus epidemiology, which includes zoonotic spread and outbreaks outside Africa, but those data apply to monkeypox rather than smallpox [3].
Source-backed transmission detail for smallpox is not yet available in the supplied snippets. The materials do indicate that related orthopoxvirus infections may involve interactions or activities with infected animals or individuals, but that exposure pattern is described for monkeypox and should not be generalized beyond the evidence provided [3].
The supplied sources do not provide a formal risk-group profile for smallpox. They do note that severe poxvirus pneumonia can occur in immunocompromised patients in the context of vaccinia or mpox, but this is not direct evidence for smallpox-specific risk stratification [1]. Source-backed detail on age, occupational, travel-related, or immunologic risk groups for smallpox is not yet available in the provided snippets [1].
The sources indicate that vaccines against smallpox/mpox are part of current vaccine-development and preparedness discussions and are included in the US Strategic National Stockpile [2]. The material also notes historical smallpox vaccination and references the continued relevance of vaccination in preparedness contexts [2][4][5]. Source-backed detail on specific immunization schedules, outbreak-control procedures, or exposure prophylaxis is not yet available in the supplied snippets [2].
In surveillance contexts, smallpox should be read as a historically eradicated but strategically important orthopoxvirus disease rather than a routine endemic diagnosis, based on the supplied material [1][2]. The sources emphasize its relevance to preparedness, stockpiling, and biological-threat assessment, so any detection signal would be high-consequence and operationally significant [1][2]. Source-backed detail on routine case definitions or contemporary reporting pathways is not yet available in the provided material [2][1].
- 1 Nucera F et al. Poxviridae Pneumonia. Adv Exp Med Biol. 2024. PMID: 38801579. doi: 10.1007/978-3-031-57165-7_12. PubMed: https://pubmed.ncbi.nlm.nih.gov/38801579/
- 2 Hammershaimb EAD et al. Vaccine Development. Pediatr Clin North Am. 2024 Jun. PMID: 38754940. doi: 10.1016/j.pcl.2024.01.018. PubMed: https://pubmed.ncbi.nlm.nih.gov/38754940/
- 3 Bunge EM et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022 Feb. PMID: 35148313. doi: 10.1371/journal.pntd.0010141. PubMed: https://pubmed.ncbi.nlm.nih.gov/35148313/
- 4 Smallpox and smallpox vaccination. PsycEXTRA Dataset. 2003. doi: 10.1037/e411352008-001. DOI: https://doi.org/10.1037/e411352008-001
- 5 Smallpox and Smallpox Vaccination. New England Journal of Medicine. 2003. doi: 10.1056/nejm200305083481914. DOI: https://doi.org/10.1056/nejm200305083481914
- 6 Smallpox and smallpox vaccination. Neurology. 2003. doi: 10.1212/01.wnl.0000063319.64515.6b. DOI: https://doi.org/10.1212/01.wnl.0000063319.64515.6b
- B03
Figure 1 | Full historical trajectories across all reporting countries.
Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.
Dataset Archive
Supplementary Data | Multi-country disease dataset
Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.
Source Register
Official sources and update cadences used to construct the downloadable dataset.
Hong Kong, China
Hong Kong, China CHP annual notifiable infectious disease CSVs normalized to national monthly totals
Official sourceJapan
Japan weekly infectious disease surveillance via NIID/JIHS.
Official sourceSouth Korea
Korea KDCA notifiable infectious disease OpenAPI or portal/KOSIS downloads aggregated to national monthly notification counts.
Official sourceUnited States
CDC National Notifiable Diseases Surveillance System provisional data.
Official source